Argitalpenak (47) LUCÍA ORDIERES ORTEGA argitalpenak

2024

  1. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

    Archivos de Bronconeumologia, Vol. 60, Núm. 3, pp. 143-152

  2. Cerebral venous thrombosis

    Revista Clinica Espanola, Vol. 224, Núm. 4, pp. 237-244

  3. Clinical Presentation and Outcomes of Patients with Cancer-Associated Isolated Distal Deep Vein Thrombosis

    Journal of Clinical Oncology, Vol. 42, Núm. 5, pp. 529-537

  4. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

    Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 8, pp. 2234-2246

  5. External validation of a prognostic score to identify low-risk outpatients with acute deep venous thrombosis in the lower limbs

    European Journal of Internal Medicine

  6. Quantitative sensory testing defines the trajectory of sensory neuropathy after severe COVID-19

    Diabetes Research and Clinical Practice, Vol. 207

  7. Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine

    European Journal of Clinical Investigation

  8. Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study

    eClinicalMedicine, Vol. 73

  9. The prognostic value of blood cellular indices in pulmonary embolism

    American Journal of Hematology, Vol. 99, Núm. 9, pp. 1704-1711

  10. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

    Blood Advances, Vol. 8, Núm. 18, pp. 4950-4959

2023

  1. Mesenteric venous thrombosis

    Medicina Clinica, Vol. 160, Núm. 9, pp. 400-406

  2. Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry

    Scientific Reports, Vol. 13, Núm. 1

  3. Whole-Blood Gene Expression Profiles Associated with Mortality in Community-Acquired Pneumonia

    Biomedicines, Vol. 11, Núm. 2

2022

  1. Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 Registry

    Internal and Emergency Medicine, Vol. 17, Núm. 3, pp. 761-775

  2. Duplex Ultrasound Screening for Deep and Superficial Vein Thrombosis in COVID-19 Patients

    Journal of Ultrasound in Medicine, Vol. 41, Núm. 5, pp. 1095-1100

2021

  1. Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis

    Journal of Thrombosis and Haemostasis, Vol. 19, Núm. 8, pp. 1981-1989

  2. Enfermedad tromboembólica venosa en poblaciones específicas: mucho por aprender

    Galicia Clínica, Vol. 82, Núm. 4, pp. 184-185

  3. Evolution of the use of corticosteroids for the treatment of hospitalised COVID-19 patients in Spain between March and November 2020: SEMI-COVID national registry

    Journal of Clinical Medicine, Vol. 10, Núm. 19

  4. Good's syndrome: Case report

    Medicina Clinica

  5. Inflammatory biomarkers in the short-term prognosis of venous thromboembolism: A narrative review

    International Journal of Molecular Sciences, Vol. 22, Núm. 5, pp. 1-14